Breast Cancer
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Feature
How is oncology adapting to COVID-19?
Feature
‘Like a coin flip’: Assay denies some cancer patients new drug
Investigators find fault with an assay used to determine which triple-negative breast cancer patients are eligible to receive atezolizumab.
From the Journals
Study supports genetic testing for all breast cancer patients age 65 and younger
From the Journals
New study suggests milk could increase breast cancer risk
Drinking 1/4 to 1/3 cup of dairy milk per day was associated with a 30% increased risk of developing breast cancer.
From the Journals
Abbreviated MRI bests digital breast tomosynthesis in finding cancer in dense breasts
Among women with dense breasts, abbreviated breast MRI identified more cases of invasive breast cancer, compared with digital breast tomosynthesis...
Conference Coverage
Abbreviated MRI equals standard protocol for high-risk breast cancer screens
CHICAGO – Cancer detection rates were similar, but fewer patients had false-positive findings or benign lesions biopsied with the shorter scans....
Expert Commentary
Breast cancer chemoprophylaxis in high-risk women: How persistent is the impact of an aromatase inhibitor after 5 years of use?
Among postmenopausal women at high risk for breast cancer, those treated with anastrozole (N = 1,920) compared with placebo (N = 1,944)...
Expert Commentary
Should supplemental MRI be used in otherwise average-risk women with extremely dense breasts?
Recent data show that supplemental MRI screening in women with extremely dense breasts and negative screening mammograms decreases the rate of...
From the Journals
Insurance coverage mediates racial disparities in breast cancer
“Without insurance coverage, the lack of prevention, screening, and access to care, as well as delays in diagnosis, lead to later stage of disease...
From the Journals
Bilateral mastectomy reduces second breast cancer risk, but not deaths
The risk of second contralateral breast cancer is low regardless of primary breast cancer therapy, results of a retrospective study show.